The FDA Wednesday sent warning letters to three baby-formula makers as part of what the agency called enhanced oversight of a product plagued by recalls and.
Perrigo Co. PLC’s stock soared 6% in premarket trade Thursday, after the company said the U.S. Food and Drug Administration has approved its over-the-counter.